PT-141
PT-141
PT-141, also known as bremelanotide, is a synthetic peptide studied for its activity at melanocortin receptors, particularly MC4R. Research has examined how this signalling relates to sexual desire and arousal.
In simple terms: researchers study PT-141 to understand how signalling in the brain influences sexual desire and response.
This product is supplied for controlled laboratory research. Refer to the individual listing and batch documentation for the vial strength and product specifications.
Product Details
| Component | Details |
|---|---|
| Compound | PT-141 |
| Also known as | Bremelanotide |
| Research category | Melanocortin receptor and sexual response research |
| Vial strength | As stated on the selected product listing |
What Is PT-141 Studied For?
Preclinical and laboratory research only
Melanocortin receptor activity: Researchers examine how PT-141 activates melanocortin receptors involved in central nervous system signalling.
Sexual desire: Clinical studies of bremelanotide have measured changes in reported sexual desire in premenopausal women with hypoactive sexual desire disorder. Results for a regulated clinical formulation do not establish the effects of this research-use vial.
Sexual response: Studies have also explored measures of arousal and distress related to sexual function.
How to Store
Unopened vial: Keep sealed, dry, and protected from light. Refrigerate for short term use and freeze for long-term use.
Research Use Notice
FOR RESEARCH PURPOSES ONLY. This Riptide vial is intended for laboratory research and is not offered for human or veterinary use. It is not intended for therapeutic or diagnostic purposes.